Unichem Laboratories has received the Establishment Inspection Report (EIR) from United Stated Food and Drug Administration (USFDA) on May 13, 2020 for its Active Pharmaceutical Ingredients (APIs) facility at Roha. The USFDA conducted the inspection of its Roha facility from February 17, 2020 to February 21, 2020.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
